Rigil Biotech Private Limited, a active private limited company, was established on 30 June 2004 in New Delhi, Delhi, India. Engaging in flavouring & seasoning additives within the support service to organizations sector, it holds CIN: U24239DL2004PTC127280. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Shivendra Kumar Srivastava (Managing Director), Gaurav Agarwal (Director). Past directors included Shivendra Kumar Srivastava. It holds ₹5.10 Cr open charges and ₹2.17 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P-97, 3Rd Floor, South Extension, Part- Ii, New Delhi, Delhi, 110049.
U24239DL2004PTC127280
127280
30 June 2004
₹1.00 M
₹0.40 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rigil Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivendra Kumar Srivastava | Managing Director | 30 Jun 2004 | Current |
| Gaurav Agarwal | Director | 30 Jun 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rigil Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10827.23% increase. The company also saw a substantial improvement in profitability, with a 12143.59% increase in profit. The company's net worth Soared by an impressive increase of 11179.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rigil Biotech had a public holding of 25.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,015,514.00
₹21,714,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2023 | Others | ₹5.10 Cr | Open |
| 19 Sep 2016 | Others | ₹1.60 Cr | Satisfied |
| 31 Aug 2015 | Hdb Financial Services Limited | ₹5.70 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rigil Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rigil Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rigil Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 51.02 M registered on 21 Dec 2023 with Charge ID 100832360 was modified on 14 Jan 2025. was recorded as a recent event.
Rigil Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rigil Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others amounted to Rs. 51.02 M with Charge ID 100832360 was registered on 21 Dec 2023. was recorded as a recent event.
Progress on A charge registered on 19 Sep 2016 via Charge ID 100065155 with Others was fully satisfied on 17 Nov 2022. was documented.
The activity A charge with Others of Rs. 16.01 M registered on 19 Sep 2016 with Charge ID 100065155 was modified on 03 Sep 2020. was completed.
The CIN of Rigil Biotech Private Limited is U24239DL2004PTC127280.
Rigil Biotech Private Limited is headquartered at P-97, 3Rd Floor, South Extension, Part- Ii, New Delhi, Delhi, 110049.
Rigil Biotech Private Limited was incorporated on 30 June 2004.
The current directors of Rigil Biotech Private Limited are
The primary industry of Rigil Biotech Private Limited is Support Service To Organizations.
Rigil Biotech Private Limited is unlisted.
The authorized capital of Rigil Biotech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Rigil Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX